Article Versions Notes

Kamara S, Wen H, Guo Y, Liu Y, Liu L, Du W, Chen J, Zhu S, Zhang L. Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma. Cells. 2024; 13(22):1823. https://doi.org/10.3390/cells13221823

Kamara, Saidu, He Wen, Yanru Guo, Ying Liu, Lei Liu, Wangqi Du, Jun Chen, Shanli Zhu, and Lifang Zhang. 2024. "Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma" Cells 13, no. 22: 1823. https://doi.org/10.3390/cells13221823

Kamara, S., Wen, H., Guo, Y., Liu, Y., Liu, L., Du, W., Chen, J., Zhu, S., & Zhang, L. (2024). Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma. Cells, 13(22), 1823. https://doi.org/10.3390/cells13221823